Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Broadwin

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Physiological Reports|December 19, 2023
Diabetic state of human coronary artery endothelial cells results in altered effects of bone mesenchymal stem cell-derived extracellular vesiclesCynthia M Xu, Catherine Karbasiafshar, Rayane Brinck-Teixeira, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 30, 2024
Gender, race, and ethnicity in lung cancer clinical trial participation: Analysis of 253,845 patients from 2002 to 2021Meghamsh Kanuparthy, Srikur Kanuparthy, Dwight D Harris, et al.
Bioengineering (Basel, Switzerland)|March 27, 2024
Exploring Electrospun Scaffold Innovations in Cardiovascular Therapy: A Review of Electrospinning in Cardiovascular DiseaseMark Broadwin, Frances Imarhia, Amy Oh, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 5, 2025
Linagliptin exerts a sex-specific effect on cardiac function, collateralization, and metabolism in a swine model of cardiometabolic diseaseKelsey C Muir, Dwight D Harris, Christopher Stone, et al.
Asian Cardiovascular & Thoracic Annals|July 3, 2025
Canagliflozin, a sodium-glucose cotransporter-2 inhibitor, reduces lung fibrosis in left heart dysfunctionMeghamsh Kanuparthy, Dwight D Harris, Mark Broadwin, et al.
Journal of Clinical Medicine|September 27, 2025
Targeting Mitochondrial Reactive Oxygen Species: JP4-039's Potential as a Cardiovascular TherapeuticKeertana Yalamanchili, Mark Broadwin, Dwight D Harris, et al.
The Journal of Surgical Research|September 18, 2023
Patient Outcomes in Traumatic Subarachnoid Hemorrhage: A Retrospective AnalysisMark Broadwin, Puja Patel, Tara Stansbury, et al.
Vessel Plus|May 30, 2024
Lack of cardiac benefit after intramyocardial or intravenous injection of mesenchymal stem cell-derived extracellular vesicles supports the need for optimized cardiac deliveryCynthia M Xu, Mark Broadwin, Patrick Faherty, et al.
JTCVS Open|August 25, 2022
Comparison of intraoperative tranexamic acid and epsilon-aminocaproic acid in cardiopulmonary bypass patientsMark Broadwin, Patrick E Grant, Michael P Robich, et al.
European Journal of Pharmacology|July 19, 2025
Sodium-glucose Cotransporter-2 Canagliflozin's impact on cardiovascular disease in the setting of metabolic syndrome: A proteomic analysisJad Hamze, Dwight D Harris, Christopher Stone, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Physiological Reports|December 19, 2023
Diabetic state of human coronary artery endothelial cells results in altered effects of bone mesenchymal stem cell-derived extracellular vesiclesCynthia M Xu, Catherine Karbasiafshar, Rayane Brinck-Teixeira, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 30, 2024
Gender, race, and ethnicity in lung cancer clinical trial participation: Analysis of 253,845 patients from 2002 to 2021Meghamsh Kanuparthy, Srikur Kanuparthy, Dwight D Harris, et al.
Bioengineering (Basel, Switzerland)|March 27, 2024
Exploring Electrospun Scaffold Innovations in Cardiovascular Therapy: A Review of Electrospinning in Cardiovascular DiseaseMark Broadwin, Frances Imarhia, Amy Oh, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 5, 2025
Linagliptin exerts a sex-specific effect on cardiac function, collateralization, and metabolism in a swine model of cardiometabolic diseaseKelsey C Muir, Dwight D Harris, Christopher Stone, et al.
Asian Cardiovascular & Thoracic Annals|July 3, 2025
Canagliflozin, a sodium-glucose cotransporter-2 inhibitor, reduces lung fibrosis in left heart dysfunctionMeghamsh Kanuparthy, Dwight D Harris, Mark Broadwin, et al.
Journal of Clinical Medicine|September 27, 2025
Targeting Mitochondrial Reactive Oxygen Species: JP4-039's Potential as a Cardiovascular TherapeuticKeertana Yalamanchili, Mark Broadwin, Dwight D Harris, et al.
The Journal of Surgical Research|September 18, 2023
Patient Outcomes in Traumatic Subarachnoid Hemorrhage: A Retrospective AnalysisMark Broadwin, Puja Patel, Tara Stansbury, et al.
Vessel Plus|May 30, 2024
Lack of cardiac benefit after intramyocardial or intravenous injection of mesenchymal stem cell-derived extracellular vesicles supports the need for optimized cardiac deliveryCynthia M Xu, Mark Broadwin, Patrick Faherty, et al.
JTCVS Open|August 25, 2022
Comparison of intraoperative tranexamic acid and epsilon-aminocaproic acid in cardiopulmonary bypass patientsMark Broadwin, Patrick E Grant, Michael P Robich, et al.
European Journal of Pharmacology|July 19, 2025
Sodium-glucose Cotransporter-2 Canagliflozin's impact on cardiovascular disease in the setting of metabolic syndrome: A proteomic analysisJad Hamze, Dwight D Harris, Christopher Stone, et al.
Pageof 5